ERDİŞ, E. 2013. Antiangiogenic Behaviours of Heparin Derivatives May Effect Survival in Lung Cancer. Thrombosis Research , vol.132, no.3 , 166.

ERDİŞ, E., (2013). Antiangiogenic Behaviours of Heparin Derivatives May Effect Survival in Lung Cancer. Thrombosis Research , vol.132, no.3, 166.

ERDİŞ, EDA. "Antiangiogenic Behaviours of Heparin Derivatives May Effect Survival in Lung Cancer," Thrombosis Research , vol.132, no.3, 166, 2013

ERDİŞ, EDA. "Antiangiogenic Behaviours of Heparin Derivatives May Effect Survival in Lung Cancer." Thrombosis Research , vol.132, no.3, pp.166, 2013

ERDİŞ, E. (2013) . "Antiangiogenic Behaviours of Heparin Derivatives May Effect Survival in Lung Cancer." Thrombosis Research , vol.132, no.3, p.166.

@article{article, author={EDA ERDİŞ}, title={Antiangiogenic Behaviours of Heparin Derivatives May Effect Survival in Lung Cancer}, journal={Thrombosis Research}, year=2013, pages={166} }